This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dien, J. Articles by Lai, R. Search for Related Content PubMed PubMed Citation Articles by Dien, J. Articles by Lai, R.

(American Journal of Pathology. 2006;169:633-642.)
© 2006 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2006.051109

Signal Transducers and Activators of Transcription-3 Up-Regulates Tissue Inhibitor of Metalloproteinase-1 Expression and Decreases Invasiveness of Breast Cancer

Jennifer Dien^*, Hesham M. Amin, Neil Chiu, Winson Wong^*, Christine Frantz^*, Brian Chiu^*, John R. Mackey and Raymond Lai^*

From the Department of Laboratory Medicine and Pathology,^* University of Alberta, Edmonton, Alberta, Canada; the Department of Medicine, Cross Cancer Institute, Edmonton, Alberta, Canada; and the Department of Hematopathology, the University of Texas M.D. Anderson Cancer Center, Houston, Texas

Signal transducers and activators of transcription (STAT)-3 is an oncogenic protein that is constitutively activated in many human cancers, including 30 to 60% of primary breast cancer. The biological significance of STAT3 activation in breast cancer is not fully understood. We have previously shown that STAT3 up-regulates tissue inhibitors of metalloproteinase (TIMP)-1, a cytokine known to block metalloproteinases and decrease invasiveness in certain cancer cell types. We hypothesize that STAT3 activation may modulate tumor invasiveness of breast cancer by regulating TIMP1 expression. Using MCF-7 cells transfected with tetracycline-off STAT3C (constitutively active STAT3), we generated an in vitro system in which STAT3C levels can be tightly controlled in breast cancer cells. Increasing tetracycline levels gradually decreased STAT3C and TIMP1 in a dose-dependent manner, and down-regulation of these proteins led to a reciprocal decrease in invasiveness of these cells in Matrigel. Addition of a neutralizing anti-TIMP1 antibody increased invasiveness in the same experimental system. Using immunohistochemistry and 142 primary breast tumors, we found a significant association between the expression of the phosphorylated/active form of STAT3 (pSTAT3) and that of TIMP1. Importantly, STAT3 activation correlated significantly with a lower frequency of vascular and lymphatic invasion (P = 0.015 and P = 0.0002, respectively). Our data support the concept that STAT3 activation significantly modulates the biological and clinical behavior of breast cancer.

This article has been cited by other articles:

				J. D. Bard, P. Gelebart, H. M. Amin, L. C. Young, Y. Ma, and R. Lai Signal transducer and activator of transcription 3 is a transcriptional factor regulating the gene expression of SALL4 FASEB J, May 1, 2009; 23(5): 1405 - 1414. [Abstract] [Full Text] [PDF]

				P. Paiva, L. A. Salamonsen, U. Manuelpillai, and E. Dimitriadis Interleukin 11 Inhibits Human Trophoblast Invasion Indicating a Likely Role in the Decidual Restraint of Trophoblast Invasion During Placentation Biol Reprod, February 1, 2009; 80(2): 302 - 310. [Abstract] [Full Text] [PDF]

				M. Segarra, A. Garcia-Martinez, M. Sanchez, J. Hernandez-Rodriguez, E. Lozano, J. M Grau, and M. C Cid Gelatinase expression and proteolytic activity in giant-cell arteritis Ann Rheum Dis, November 1, 2007; 66(11): 1429 - 1435. [Abstract] [Full Text] [PDF]